These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20672243)

  • 1. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
    Drye LT; Martin BK; Frangakis CE; Meinert CL; Mintzer JE; Munro CA; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
    Int J Geriatr Psychiatry; 2011 Jun; 26(6):573-83. PubMed ID: 20672243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Depression in Alzheimer's Disease Study-2.
    Martin BK; Frangakis CE; Rosenberg PB; Mintzer JE; Katz IR; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Niederehe G; Lyketsos CG
    Am J Geriatr Psychiatry; 2006 Nov; 14(11):920-30. PubMed ID: 17068314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.
    Lyketsos CG; Sheppard JM; Steele CD; Kopunek S; Steinberg M; Baker AS; Brandt J; Rabins PV
    Am J Psychiatry; 2000 Oct; 157(10):1686-9. PubMed ID: 11007727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline for the treatment of depression in Alzheimer disease.
    Rosenberg PB; Drye LT; Martin BK; Frangakis C; Mintzer JE; Weintraub D; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG;
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):136-45. PubMed ID: 20087081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.
    Mayer LS; Bay RC; Politis A; Steinberg M; Steele C; Baker AS; Rabins PV; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):930-6. PubMed ID: 16955427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
    Peters ME; Vaidya V; Drye LT; Rosenberg PB; Martin BK; Porsteinsson AP; Frangakis CE; Mintzer J; Weintraub D; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG; Avramopoulos D;
    J Geriatr Psychiatry Neurol; 2011 Dec; 24(4):222-8. PubMed ID: 22228829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
    Weintraub D; Rosenberg PB; Drye LT; Martin BK; Frangakis C; Mintzer JE; Porsteinsson AP; Schneider LS; Rabins PV; Munro CA; Meinert CL; Lyketsos CG;
    Am J Geriatr Psychiatry; 2010 Apr; 18(4):332-40. PubMed ID: 20220589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
    Finkel SI; Mintzer JE; Dysken M; Krishnan KR; Burt T; McRae T
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):9-18. PubMed ID: 14716694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).
    Munro CA; Brandt J; Sheppard JM; Steele CD; Samus QM; Steinberg M; Rabins PV; Lyketsos CG
    Am J Geriatr Psychiatry; 2004; 12(5):491-8. PubMed ID: 15353387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
    Flynn Longmire CV; Drye LT; Frangakis CE; Martin BK; Meinert CL; Mintzer JE; Munro CA; Porsteinsson AP; Rabins PV; Rosenberg PB; Schneider LS; Weintraub D; Lyketsos CG;
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):14-24. PubMed ID: 24314887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
    Banerjee S; Hellier J; Dewey M; Romeo R; Ballard C; Baldwin R; Bentham P; Fox C; Holmes C; Katona C; Knapp M; Lawton C; Lindesay J; Livingston G; McCrae N; Moniz-Cook E; Murray J; Nurock S; Orrell M; O'Brien J; Poppe M; Thomas A; Walwyn R; Wilson K; Burns A
    Lancet; 2011 Jul; 378(9789):403-11. PubMed ID: 21764118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study.
    Steinberg M; Munro CA; Samus Q; V Rabins P; Brandt J; Lyketsos CG
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):144-50. PubMed ID: 14758580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
    Murray V; von Arbin M; Bartfai A; Berggren AL; Landtblom AM; Lundmark J; Näsman P; Olsson JE; Samuelsson M; Terént A; Varelius R; Asberg M; Mårtensson B
    J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
    Rocca P; Calvarese P; Faggiano F; Marchiaro L; Mathis F; Rivoira E; Taricco B; Bogetto F
    J Clin Psychiatry; 2005 Mar; 66(3):360-9. PubMed ID: 15766303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial.
    Zuidersma M; Chua KC; Hellier J; Voshaar RO; Banerjee S;
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):920-931. PubMed ID: 31084994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.